ICC International Cannabis Corp (CSE:WRLD) has expanded its land holdings in Denmark and now controls a 100-acre property in the municipality of Moeldrup.
The start of development work, as well as the adaptation of infrastructure for the property is set to begin in January of next year.
International Cannabis’ Danish operations are strategically located along a national highway in western Denmark, permitting direct access to the capital of Copenhagen.
The land parcel has favorable lease terms and is equipped with the requisite utilities, including water, gas, telecommunications and electricity.
Stage A of the company’s Danish medical cannabis facility will include a 49,600 square foot cultivation unit, an administrative area as well as a production and processing structure.
Israeli cannabis cultivation company hired
International Cannabis has hired an Israeli cannabis organic cultivation and management company Sababa Sciences to help with the build-out of its Danish medical cannabis cultivation facility.
On top of this move, the company has also engaged the leading greenhouse engineering and manufacturing firm Azrom to assist with facility engineering planning. Under Sababa’s guidance, Azrom will provide end-to-end planning and consulting services throughout the build out of the Danish medical cannabis cultivation facility.
“International Cannabis continues to make material progress towards a world-class cultivation facility in Denmark,” said Eugene Beukman, CEO of International Cannabis in a statement. “Through its partnerships with Sababa and Azrom, the Company is working with world-renowned experts in greenhouse engineering, manufacturing and construction.”
International Cannabis expects its greenhouse engineering planning work will be completed by December 31. Once finalized, delivery of the greenhouse structure and the required growing systems is set to take place by the end of the first quarter of 2019.
READ: ICC International Cannabis partners with Amercanex parent on globe's first cannabis market digital platform
The company is also in the process of applying for building permits and its architects and engineers are now finalizing the project plan for the cultivation facilities.
International Cannabis’s land development campaign for its Danish project include the completion of a mandatory museum/archaeological survey, removal of trees, shrubs and bushes and installation of temporary housing to serve as a command and control center for construction and engineering staff.
The company has also finalized the design of its European GMP compliant manufacturing facility. Construction of the facility will kick off during the second quarter of 2019 and it is expected that it will see GMP validation before the end of next year.
At the same time as its construction and manufacturing efforts are advancing, International Cannabis is still bolstering its genetic and strain catalogue of cannabis via the purchase of 10 varieties of seeds from several different suppliers. The company has established a genetics room that will be monitored by Sababa’s agronomy team.
The company now has access to 130 laboratory-tested craft cannabis strains. The finished cannabis and cannabis derivatives it produces will eventually be sold through Denmark’s retail pharmacy network.
Denmark has developed a program for reimbursement for cannabis therapeutics through its national health care program. Patients can be reimbursed for their cannabis medicine in the same manner as all other prescriptions.
ICC International Cannabis has licences to cultivate, produce and export cannabis, cannabis derivatives and industrial hemp in Colombia, Denmark, Poland, Greece, Portugal, South Africa and the Kingdom of Lesotho.
ICC International Cannabis shares nudged up 11.7% to hit C$0.43 on Tuesday.
Contact Ellen Kelleher at [email protected]